Silver Creek Pharmaceuticals
San Francisco
About Silver Creek Pharmaceuticals
Silver Creek Pharmaceuticals, a biotechnology company, develops protein therapeutics to treat cardiovascular diseases. The company's mission is to provide smart growth factors to those suffering from organ damage as a result of an acute injury. Scp776 is currently being tested in clinical trials for the treatment of stroke.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.1M
- Last round: Debt Financing (Feb 2022)
- Website: silvercreekpharma.com
- Phone: 4159781930
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/silver-creek-pharmaceuticals-34084 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.